5004202025-01-012025-03-315004202025-03-315004202025-01-012025-03-31CompositionOfBoardOfDirectors15004202025-03-31CompositionOfBoardOfDirectors15004202025-01-012025-03-31CompositionOfBoardOfDirectors25004202025-03-31CompositionOfBoardOfDirectors25004202025-01-012025-03-31CompositionOfBoardOfDirectors35004202025-03-31CompositionOfBoardOfDirectors35004202025-01-012025-03-31CompositionOfBoardOfDirectors45004202025-03-31CompositionOfBoardOfDirectors45004202025-01-012025-03-31CompositionOfBoardOfDirectors55004202025-03-31CompositionOfBoardOfDirectors55004202025-01-012025-03-31CompositionOfBoardOfDirectors65004202025-03-31CompositionOfBoardOfDirectors65004202025-01-012025-03-31CompositionOfBoardOfDirectors75004202025-03-31CompositionOfBoardOfDirectors75004202025-01-012025-03-31CompositionOfBoardOfDirectors85004202025-03-31CompositionOfBoardOfDirectors85004202025-01-012025-03-31CompositionOfCommittees145004202025-03-31CompositionOfCommittees145004202025-01-012025-03-31CompositionOfCommittees155004202025-03-31CompositionOfCommittees155004202025-01-012025-03-31CompositionOfCommittees165004202025-03-31CompositionOfCommittees165004202025-01-012025-03-31CompositionOfCommittees175004202025-03-31CompositionOfCommittees175004202025-01-012025-03-31CompositionOfCommittees415004202025-03-31CompositionOfCommittees415004202025-01-012025-03-31CompositionOfCommittees425004202025-03-31CompositionOfCommittees425004202025-01-012025-03-31CompositionOfCommittees435004202025-03-31CompositionOfCommittees435004202025-01-012025-03-31CompositionOfCommittees685004202025-03-31CompositionOfCommittees685004202025-01-012025-03-31CompositionOfCommittees695004202025-03-31CompositionOfCommittees695004202025-01-012025-03-31CompositionOfCommittees705004202025-03-31CompositionOfCommittees705004202025-01-012025-03-31CompositionOfCommittees955004202025-03-31CompositionOfCommittees955004202025-01-012025-03-31CompositionOfCommittees965004202025-03-31CompositionOfCommittees965004202025-01-012025-03-31CompositionOfCommittees975004202025-03-31CompositionOfCommittees975004202025-01-012025-03-31CompositionOfCommittees985004202025-03-31CompositionOfCommittees985004202025-01-012025-03-31CompositionOfCommittees1225004202025-03-31CompositionOfCommittees1225004202025-01-012025-03-31CompositionOfCommittees1235004202025-03-31CompositionOfCommittees1235004202025-01-012025-03-31CompositionOfCommittees1245004202025-03-31CompositionOfCommittees1245004202025-03-31MeetingOfBoardOfDirectors15004202025-01-012025-03-31MeetingOfBoardOfDirectors15004202025-03-31MeetingOfBoardOfDirectors25004202025-01-012025-03-31MeetingOfBoardOfDirectors25004202025-01-012025-03-31MeetingOfCommittees15004202025-03-31MeetingOfCommittees15004202025-01-012025-03-31MeetingOfCommittees25004202025-03-31MeetingOfCommittees25004202025-01-012025-03-31MeetingOfCommittees35004202025-03-31MeetingOfCommittees35004202025-01-012025-03-31MeetingOfCommittees45004202025-03-31MeetingOfCommittees45004202024-12-315004202025-03-31ImpositionOfFineOrPenaltyDomain15004202025-03-31ImpositionOfFineOrPenaltyDomain25004202025-03-31ImpositionOfFineOrPenaltyDomain35004202025-03-31ImpositionOfFineOrPenaltyDomain45004202025-03-31ImpositionOfFineOrPenaltyDomain55004202025-03-31ImpositionOfFineOrPenaltyDomain65004202025-03-31ImpositionOfFineOrPenaltyDomain7xbrli:pure500420TORNTPHARMNOTLISTEDINE685A01028Torrent Pharmaceuticals Limited2024-04-012025-03-31Yearly2025-03-31EquitytruetruefalseNot Applicable during this quarter truefalseNot Applicable during this quarter falseNot Applicable during 01-10-2024 to 31-03-2025 trueTop 100 listed entitiestrueT00128Original 1. The Chairperson is in Executive Position and categorized as Managing Director. 2. Ms. Nayantara Bali have been appointed for the period of three years w.e.f 07-Mar-2019. Reappointed for the period of 5 years w.e.f. 07-Mar-2022. 3. Ms. Ameera Shah was appointed for the period of 3 years w.e.f. 02-Aug-2018. Reappointed for the period of 5 years w.e.f. 02-Aug-2021. 4. Maurice Chagnaud Appointed for period of 3 years 5. Manish Choksi appointed for period of 5 years. 6. Nikhil Khattau appointed for period of 5 years. 7. SEBI vide its circular dated 16th July, 2019 revised the format for filling Corporate Governance Report (CGR) which provides disclosure of Chairmanship in Audit Committee & Stakeholders committee held in "listed entities" only. However, guidance note issued by NSE in this respect provides to submit information related to Chairmanship in Audit Committee & Stakeholders Committee of all "public companies whether listed or unlisted". Hence, we have considered the guidance note provided by NSE while preparing CGR and have provided Chairmanship of Audit and Stakeholder Committee for all the public companies, whether listed or not.truetrueMrSamir Uttamlal Mehta00061903Executive DirectorChairpersonCEO-MD1963-09-18falseNA1986-08-202020-04-012010MsAmeera Sushil ShahAUXPS8105R00208095Non-Executive - Independent DirectorNot Applicable1979-09-24falseNA2018-08-022021-08-02803231MsNayantara Bali03570657Non-Executive - Independent DirectorNot Applicable1966-06-13falseNA2019-03-072022-03-07732220MrMaurice ChagnaudZZZZZ9999Z09592878Non-Executive - Independent DirectorNot Applicable1961-03-28falseNA2022-05-11351110No PAN as foreign nationalMrManish Mahendra Choksi00026496Non-Executive - Independent DirectorNot Applicable1967-09-12falseNA2022-07-29324340MrAman MehtaAOWPM3837K08174906Executive DirectorNot Applicable1991-08-28falseNA2022-08-011010MrNikhil Nirvan Khattau00017880Non-Executive - Independent DirectorNot Applicable1963-03-20falseNA2023-10-01183243MrJinal Sudhirbhai MehtaAFVPM9728F02685284Non-Executive - Non Independent DirectorNot Applicable1983-03-11falseNA2024-05-242000truetruetruetruetrueAudit Committee00017880Nikhil Nirvan KhattauNon-Executive - Independent DirectorChairperson2023-10-14Mr. Nikhil Khattau has been appointed as Chairperson of the Committee wef from 24-May-24.Audit Committee00208095Ameera Sushil ShahNon-Executive - Independent DirectorMember2018-08-02Audit Committee03570657Nayantara BaliNon-Executive - Independent DirectorMember2019-04-06Audit Committee09592878Maurice ChagnaudNon-Executive - Independent DirectorMember2022-05-11Nomination and remuneration committee00026496Manish Mahendra ChoksiNon-Executive - Independent DirectorChairperson2023-10-14Mr. Manish Choksi has been appointed as Chairperson of the Committee wef from 24-May-24.Nomination and remuneration committee03570657Nayantara BaliNon-Executive - Independent DirectorMember2021-02-08Nomination and remuneration committee00208095Ameera Sushil ShahNon-Executive - Independent DirectorMember2023-10-14Stakeholders Relationship Committee00208095Ameera Sushil ShahNon-Executive - Independent DirectorChairperson2018-08-02Ms. Ameera Shah has been appointed as Chairperson of the Committee wef from 24-May-24.Stakeholders Relationship Committee08174906Aman MehtaExecutive DirectorMember2023-05-24Stakeholders Relationship Committee00017880Nikhil Nirvan KhattauNon-Executive - Independent DirectorMember2023-10-14Risk Management Committee00017880Nikhil Nirvan KhattauNon-Executive - Independent DirectorChairperson2023-10-14Mr. Nikhil Khattau has been appointed as Chairperson of the Committee wef from 02-Apr-24.Risk Management Committee03570657Nayantara BaliNon-Executive - Independent DirectorMember2022-05-11Risk Management Committee09592878Maurice ChagnaudNon-Executive - Independent DirectorMember2022-05-11Risk Management Committee99999999Sudhir MenonChief Financial OfficerMember2019-05-20DIN is not mentioned as he is CFO and not a directorCorporate Social Responsibility Committee03570657Nayantara BaliNon-Executive - Independent DirectorChairperson2019-04-06Ms Nayantara Bali has been appointed as chairperson of the Committee wef 21-Oct-22Corporate Social Responsibility Committee00026496Manish Mahendra ChoksiNon-Executive - Independent DirectorMember2022-07-29Corporate Social Responsibility Committee09592878Maurice ChagnaudNon-Executive - Independent DirectorMember2024-07-232024-10-25true8852025-01-2490true885Audit Committee2024-10-25true4440Audit Committee2025-01-2490true4440Corporate Social Responsibility Committee2024-10-25true3330Risk Management Committee2024-10-25true4331truetruetruetrueYestruetruetrueThe report submitted in the previous quarter was placed before Board of Directors in its meeting held on 24-Jan-25. There were no comments/observations/advice of Board of Directors on the report. This report shall be placed at the ensuing Board Meeting.CHINTAN M. TRIVEDICompany Secretary and Compliance OfficerYeshttps://torrentpharma.com/index.php/site/info/businessAreasYeshttps://www.torrentpharma.com/investors/corp-governance/moa-aoa/Yeshttps://www.torrentpharma.com/ourstory/board-of-directors/Yeswww.torrentpharma.com/assets/bod_Terms_and_Conditions_of_appointment_of_Independent_Directors_2f69a85ac4.pdfYeswww.torrentpharma.com/assets/Composition_Of_Various_Committees_Of_Board_Of_Directors_439ff7d253.pdfYeswww.torrentpharma.com/assets/Code_of_Business_Conduct_8784fdd442.pdfYeswww.torrentpharma.com/assets/WBP_b639fe8a9a.pdfNAYeswww.torrentpharma.com/assets/POLICY_ON_MATERIALITY_OF_AND_DEALING_WITH_RELATED_PARTY_bbb5bc82e4.pdfYeswww.torrentpharma.com/assets/POLICY_FOR_DETERMINATION_OF_MATERIAL_SUBSIDIARIES_d54102dd6b.pdfYeshttps://www.torrentpharma.com/assets/Familiarization_Programme_2024-25.pdfYeshttps://torrentpharma.com/index.php/investors/shareHolderYeshttps://torrentpharma.com/index.php/investors/shareHolderYeshttps://torrentpharma.com/index.php/investors/financial?fy=2023-24Yeshttps://www.torrentpharma.com/investors/corp-governance/intimation/NAYeshttps://torrentpharma.com/index.php/investors/financial?fy=2023-24Yeshttps://torrentpharma.com/index.php/investors/financial?fy=2023-24NAYeshttps://torrentpharma.com/index.php/investors/financial?fy=2023-24Yeshttps://torrentpharma.com/index.php/investors/credit_ratingsYeshttps://www.torrentpharma.com/investors/financial-info/subsidiary-reports/Yeswww.torrentpharma.com/assets/ACR_c39ebc066e.pdfYeshttps://www.torrentpharma.com/assets/Policy_on_Material_Disclosures_aa771c1f9f.pdfYeshttps://torrentpharma.com/pdf/investors/Disclosure-of-events-or-information.pdfYeshttps://www.torrentpharma.com/index.php/investors/financial?fy=2023-24NAYeshttps://www.torrentpharma.com/pdf/investors/Dividend_Policy.pdfYeshttps://www.torrentpharma.com/index.php/investors/annual_returnNAYeshttps://torrentpharma.com/index.php/investors/disclosuresYeshttps://torrentpharma.com/index.php/investors/disclosuresFor point no-6 criteria for making payment to NEDs- disclosed in AR 2023-24. Will be disclosed in AR 2024-25.YesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesNAYesNAYesNAYesYesYesYesYesYesYesYesYesYesNANACHINTAN M. TRIVEDICompany Secretary and Compliance OfficerYesCHINTAN M. TRIVEDICompany Secretary and Compliance OfficerfalseChintan M. TrivediCompany Secretary and Compliance OfficerAhmedabad2025-04-2906511Assessment Unit, Income Tax DepartmentOrder passed under Section 271(1)(c) of the Income Tax Act, 1961, imposing a penalty of Rs. 82,602/-2025-01-28The order alleges penalty on certain tax adjustments.Based on the Company assessment, the Company will pursue an appeal and is hopeful of favorable outcome at higher forum and does not expect the said Order to have any material financial impact on the Company.Assistant Commissioner of State Tax, BHIWANDI_605: BHIWANDI RaigadOrder passed under Section 73 of the Goods and Service Act, 2017, imposing a penalty of Rs. 20,000 /-2025-02-24The demand is raised in respect of alleged excess availment of ITC for the financial year 2020-21Based on the Company assessment, an appeal will be filed and the Company is hopeful of favorable outcome at the appellate level and does not reasonably expect the said Order to have any material financial impact on the Company.Superintendent of State Tax, RANGE-IV DEHRADUNOrder passed under Section 73 of the Goods and Service Act, 2017, imposing a penalty of Rs. 95,677 /-2025-02-24The demand is raised in respect of alleged excess availment of ITC for the financial year 2020-21Based on the Company assessment, an appeal will be filed and the Company is hopeful of favorable outcome at the appellate level and does not reasonably expect the said Order to have any material financial impact on the Company.Joint Commissioner of State Tax, Mohali Ward, PunjabOrder passed under Section 73 of the Goods and Service Act, 2017, imposing a penalty of Rs. 20,000 /-2025-02-28The demand is raised in respect of alleged ITC availed on ineligible credit for the financial year 2020-21The said Order doesnot have any material financial impact on the Company.Office of Deputy Commissioner, GhaziabadOrder passed under Section 73 of the Goods and Service Act, 2017, imposing a penalty of Rs 20,000 /-2025-02-05The demand is raised in resspect of alleged Generation Part-A of E-way bills and later discarded by Curatio Health Care (I) Private Limited for the financial year 2020-21. The Company acquired Curatio in October 2022 which was subsequently merged into the Company.Based on the Company assessment, an appeal will be filed and the Company is hopeful of favorable outcome at the appellate level and does not reasonably expect the said Order to have any material financial impact on the Company.Sales Tax Officer Class II / AVATO, Delhi StateOrder passed under Section 73 of the Goods and Service Act, 2017, imposing a penalty of Rs 40,000 /-2025-02-14The demand is raised in respect of alleged ITC availed on ineligible credit for the financial year 2020-21The said Order doesnot have any material financial impact on the Company.Assistant Commissioner of State Tax, Bihar StateOrder passed under Section 73 of the Goods and Service Act, 2017, imposing a penalty of Rs 4,80,441 /-2025-02-20The demand is raised in respect of alleged ITC availed on ineligible credit for the financial year 2020-21Based on the Company assessment, an appeal will be filed and the Company is hopeful of favorable outcome at the appellate level and does not reasonably expect the said Order to have any material financial impact on the Company.